Skip to main content
SpringerLink
Log in

Modafinil: risks outweigh benefits unless narcoleptic

  • Media release
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. EMA.European Medicines Agency recommends restricting the use of modafinil. Media Release: 22 Jul 2010. Available from: URL: http://www.ema.europa.eu

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Modafinil: risks outweigh benefits unless narcoleptic. React. Wkly. 1312, 7 (2010). https://doi.org/10.2165/00128415-201013120-00019

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128415-201013120-00019

Keywords

Search

Navigation